From gut microbiota dysfunction to obesity: could short-chain fatty acids stop this dangerous course?

Endocrine regulation of gut function - a role for glucagon-like peptide-1 in the pathophysiology of irritable bowel syndrome

(2018) Dervla O'Malley   EXPERIMENTAL PHYSIOLOGY

Gut microbiota: a potential manipulator for host adipose tissue and energy metabolism

(2018) Rong Bohan et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Decreased glucagon-like peptide-1 correlates with abdominal pain in patients with constipation-predominant irritable bowel syndrome

(2017) Zheng-Yang Li et al.   Clinics and Research in Hepatology and Gastroenterology

Gut Microbiota Modulation and Its Relationship with Obesity Using Prebiotic Fibers and Probiotics: A Review

(2017) Dinesh K. Dahiya et al.   Frontiers in Microbiology

Fermentable carbohydrate stimulates FFAR2-dependent colonic PYY cell expansion to increase satiety

(2017) Lucy Brooks et al.   Molecular Metabolism

Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome

(2016) T. N. Hustoft et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Gut microbiota, obesity and diabetes

(2016) Elaine Patterson et al.   POSTGRADUATE MEDICAL JOURNAL

Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health

(2016) David Ríos-Covián et al.   Frontiers in Microbiology

How gut microbes talk to organs: The role of endocrine and nervous routes

(2016) Patrice D. Cani et al.   Molecular Metabolism

Towards microbial fermentation metabolites as markers for health benefits of prebiotics

(2015) Kristin A. Verbeke et al.   NUTRITION RESEARCH REVIEWS

Dietary Gut Microbial Metabolites, Short-chain Fatty Acids, and Host Metabolic Regulation

(2015) Mayu Kasubuchi et al.   Nutrients

Altering the Intestinal Microbiota during a Critical Developmental Window Has Lasting Metabolic Consequences

(2014) Laura M. Cox et al.   CELL

Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits

(2014) Filipe De Vadder et al.   CELL

Ghrelin and Insulin Secretion in Humans: Not a Tale of Two Hormones?

(2014) R. Barazzoni   DIABETES

The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism

(2014) Gary Frost et al.   Nature Communications

Metabolic benefits of dietary prebiotics in human subjects: a systematic review of randomised controlled trials

(2013) Nicole J. Kellow et al.   BRITISH JOURNAL OF NUTRITION

GPR41/FFAR3 and GPR43/FFAR2 as Cosensors for Short-Chain Fatty Acids in Enteroendocrine Cells vs FFAR3 in Enteric Neurons and FFAR2 in Enteric Leukocytes

(2013) Mark K. Nøhr et al.   ENDOCRINOLOGY

The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43

(2013) Ikuo Kimura et al.   Nature Communications

Seven transmembrane G protein-coupled receptor repertoire of gastric ghrelin cells

(2013) Maja S. Engelstoft et al.   Molecular Metabolism

Short-chain fatty acid receptor GPR41-mediated activation of sympathetic neurons involves synapsin 2b phosphorylation

(2012) Daisuke Inoue et al.   FEBS LETTERS

Fermentable Carbohydrate Alters Hypothalamic Neuronal Activity and Protects Against the Obesogenic Environment

(2012) Jelena Anastasovska et al.   Obesity

Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein-Coupled Receptor FFAR2

(2011) G. Tolhurst et al.   DIABETES

The role of the gut/brain axis in modulating food intake

(2011) Amir H. Sam et al.   NEUROPHARMACOLOGY

Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice

(2009) Z. Gao et al.   DIABETES

Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43

(2009) Kendle M. Maslowski et al.   NATURE

Activation of G Protein-Coupled Receptor 43 in Adipocytes Leads to Inhibition of Lipolysis and Suppression of Plasma Free Fatty Acids

(2008) Hongfei Ge et al.   ENDOCRINOLOGY